Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19
Robert L. Chapman, Shridhar V. Andurkar
Medicinal Chemistry Research (2021) Vol. 31, Iss. 1, pp. 40-51
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview
Deborah Giordano, Angelo Facchiano, Virginia Carbone
Molecules (2023) Vol. 28, Iss. 6, pp. 2470-2470
Open Access | Times Cited: 17
Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic
Wan‐Yi Ho, Zi-han Shen, Yijing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30080-e30080
Open Access | Times Cited: 6
A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin
Xin-Yang Liu, Wei Xie, He‐Yang Zhou, et al.
Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 6
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19
Vicente Amirpasha Tirado-Kulieva, Ernesto Hernández, Tania Jakeline Choque Rivera
Heliyon (2022) Vol. 8, Iss. 9, pp. e10702-e10702
Open Access | Times Cited: 28
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products
Chenwei Li, Tai‐Ling Chao, Chin-Lan Lai, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23984-23997
Open Access | Times Cited: 4
Electron-Shuttling Characteristics of Cassia obtusifolia Seed Extracts and Antiviral Activities of Anthraquinone Compounds Through In Silico Studies
Stephanie Claire M. Tiongson, Bor‐Yann Chen, Kathlia A. De Castro-Cruz, et al.
Processes (2025) Vol. 13, Iss. 2, pp. 458-458
Open Access
Targeting the omicron variant of SARS-CoV-2 with phytochemicals from Saudi medicinal plants: molecular docking combined with molecular dynamics investigations
Lina Eltaib, Abdulrahim A. Alzain
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9732-9744
Closed Access | Times Cited: 17
Diversity and variability of bioactive compounds in Cannabis sativa: Effects on therapeutic and environmental uses and orientations for future research
Maryem El Oihabi, Mohammed Soultana, Mohammed Ammari, et al.
Case Studies in Chemical and Environmental Engineering (2024) Vol. 9, pp. 100732-100732
Open Access | Times Cited: 3
Exosomes, and the potential for exosome‐based interventions against COVID‐19
Abolfazl Rahmani, Ali Soleymani, Mustafa Almukhtar, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access | Times Cited: 3
Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2′-O-methyltransferase (nsp16) of SARS-CoV-2
Jobin Thomas, Sanjit Kumar, Jitendra Satija
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1999-2012
Closed Access | Times Cited: 8
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1553-1567
Open Access | Times Cited: 13
Promising natural products against SARS‐CoV‐2: Structure, function, and clinical trials
Yan Zhao, Shanshan Deng, Yujiao Bai, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 10, pp. 3833-3858
Open Access | Times Cited: 13
Screening of Some Ayurvedic Phytochemicals to Identify Potential Inhibitors against SARS-CoV-2 Mpro by In Silico Computational Approach
V. Alagarsamy, Priya Shyamsundar, Bandi Narendhar, et al.
Anti-Infective Agents (2024) Vol. 22, Iss. 5
Closed Access | Times Cited: 2
Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics
Biswanath Dinda, Subhajit Dinda, Manikarna Dinda, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100173-100173
Open Access | Times Cited: 2
Secondary metabolite profiles and anti‐SARS‐CoV‐2 activity of ethanolic extracts from nine genotypes of Cannabis sativa L.
Ermin Schadich, Dominika Kaczorová, Tibor Béreš, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Open Access | Times Cited: 2
In Silico Identification of Anti-SARS-CoV-2 Medicinal Plants Using Cheminformatics and Machine Learning
Ji-Hao Liang, Zheng Yang, Xin Tong, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 208-208
Open Access | Times Cited: 11
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
Varun Aggarwal, Ekta Bala, Pawan Kumar, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1664-1698
Closed Access | Times Cited: 6
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro
Matteo Biolatti, Marco Blangetti, Melissa Baggieri, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 7, pp. 1310-1318
Open Access | Times Cited: 4
Computational aids for assessing bioactivities in phytochemical and natural products research
Evelyn Wolfram, Adriana Trifan
Elsevier eBooks (2024), pp. 357-393
Closed Access | Times Cited: 1
Specialized compounds of four Cameroonian spices: Isolation, characterization, and in silico evaluation as prospective SARS-CoV-2 inhibitors
Gervais Mouthé Happi, Klev Gaïtan Sikam, Mahmoud A. A. Ibrahim, et al.
Open Chemistry (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Antiviral miliusanes and isolation of an unprecedented miliusane dimer from Miliusa balansae
Bastien Petit, Élodie Marguerite, Elsa Van Elslande, et al.
Fitoterapia (2024) Vol. 177, pp. 106083-106083
Closed Access | Times Cited: 1
Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality
Sunitha Kodidela, Sandip Godse, Asit Kumar, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 177-177
Open Access | Times Cited: 6
Recent advances in health biotechnology during pandemic
Selcen Arı Yuka
Sigma Journal of Engineering and Natural Sciences – Sigma Mühendislik ve Fen Bilimleri Dergisi (2023)
Open Access | Times Cited: 3
VDDB: A comprehensive resource and machine learning tool for antiviral drug discovery
Shunming Tao, Yihao Chen, Jingxing Wu, et al.
MedComm – Future Medicine (2023) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top